Treatment of Children and Adults With X-Linked Hypophosphatemia With Calcitriol Alone: A Prospective, Open-Label Study
Calcitriol monotherapy is safe and well-tolerated in XLH, with modest benefits on laboratory indices of mineral metabolism and rickets.
Authors
- Lisa Ceglia
- Theodore T. Pierce (ORCID: https://orcid.org/0000-0003-3244-0994)
- Mary Bouxsein (ORCID: https://orcid.org/0000-0002-7027-7414)
- Sara Rudolph (ORCID: https://orcid.org/0000-0002-3284-2187)
- Tom D. Thacher (ORCID: https://orcid.org/0000-0002-7644-8173)
- Sarah Gehman
- Mackenzie Jordan
- Marie B. Demay (ORCID: https://orcid.org/0000-0001-5845-5479)
- Eva S. Liu (ORCID: https://orcid.org/0000-0003-2630-6916)
- Madhusmita Misra (ORCID: https://orcid.org/0000-0002-9405-2981)
- Michael S. Gee (ORCID: https://orcid.org/0000-0002-6117-5168)
- Deborah M. Mitchell (ORCID: https://orcid.org/0000-0003-0364-9107)
- Hang Lee (ORCID: https://orcid.org/0000-0002-3498-236X)
- Harald Jüppner (ORCID: https://orcid.org/0000-0003-1420-5683)
Institutions
- Brigham and Women's Hospital (US)
- Tufts Medical Center (US)
- Beth Israel Deaconess Medical Center (US)
- Mayo Clinic (US)
- Harvard University (US)
- Massachusetts General Hospital (US)
- Mayo Clinic in Arizona (US)
- Mayo Clinic in Florida (US)
- University of Virginia (US)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-10-23
- DOI
- https://doi.org/10.1210/clinem/dgaf585
- Citations
- 1
- Primary Topic
- Parathyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.43